Saikosaponin D 25 mg | 99.09%
TargetMol
Saikosaponin D is a novel SERCA inhibitor by inhibiting NF-κB and STAT3 signaling to protect against acetaminophen-induced hepatotoxicity.
More Information Supplier PageSaikosaponin D
Search Results
FX1 200 mg | 99.68%
TargetMol
Vardenafil hydrochloride trihydrate 200 mg | Purity Not Available
TargetMol
Vardenafil HCl Trihydrate is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.
More Information Supplier PageVardenafil hydrochloride trihydrate
PKM2-IN-1 2 mg | 99.90%
TargetMol
PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.
More Information Supplier PagePKM2-IN-1
(+)-Isocorydine hydrochloride 5 mg | 99.72%
TargetMol
(+)-Isocorydine hydrochloride
(+)-Isocorydine hydrochloride 2 mg | 99.72%
TargetMol
(+)-Isocorydine hydrochloride
Endoxifen 50 mg | 99.66%
TargetMol
(E/Z)-Endoxifen is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-fold greater affinity for estrogen receptors than tamoxifen. As the efficient conversion of tamoxifen to endoxifen depends on CYP2D6, polymorphisms in this CYP isoform can impact […]
More Information Supplier PageEndoxifen
Endoxifen 10 mg | 99.66%
TargetMol
(E/Z)-Endoxifen is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-fold greater affinity for estrogen receptors than tamoxifen. As the efficient conversion of tamoxifen to endoxifen depends on CYP2D6, polymorphisms in this CYP isoform can impact […]
More Information Supplier PageEndoxifen
Endoxifen 5 mg | 99.66%
TargetMol
(E/Z)-Endoxifen is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-fold greater affinity for estrogen receptors than tamoxifen. As the efficient conversion of tamoxifen to endoxifen depends on CYP2D6, polymorphisms in this CYP isoform can impact […]
More Information Supplier PageEndoxifen
PKM2-IN-1 25 mg | 99.90%
TargetMol
PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.
More Information Supplier PagePKM2-IN-1